Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial.
Elizabeth M CurtisCamille M PearseKate MaslinStefania D'AngeloRebecca Jane MoonSarah R CrozierFatma GossielNicholas J BishopStephen H KennedyAris T PapageorghiouRobert FraserSaurabh V GandhiAnn PrenticeHazel M InskipKeith M GodfreyInez SchoenmakersM Kassim JavaidRichard EastellCyrus CooperNicholas C W Harveynull nullPublished in: The American journal of clinical nutrition (2021)
Maternal urinary CTX, a bone resorption marker, rises through pregnancy, although to a lesser degree with gestational cholecalciferol supplementation, and is inversely associated with maternal bone mass postpartum.This trial was registered at www.isrctn.com as ISRCTN 82927713 and eudract.ema.europa.eu as EudraCT 2007-001716-23.